20-3219057-G-A

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The ENST00000609835.5(ITPA):​n.890G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.887 in 209,088 control chromosomes in the GnomAD database, including 82,711 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.89 ( 61057 hom., cov: 30)
Exomes 𝑓: 0.87 ( 21654 hom. )

Consequence

ITPA
ENST00000609835.5 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.823

Publications

5 publications found
Variant links:
Genes affected
ITPA (HGNC:6176): (inosine triphosphatase) This gene encodes an inosine triphosphate pyrophosphohydrolase. The encoded protein hydrolyzes inosine triphosphate and deoxyinosine triphosphate to the monophosphate nucleotide and diphosphate. This protein, which is a member of the HAM1 NTPase protein family, is found in the cytoplasm and acts as a homodimer. Defects in the encoded protein can result in inosine triphosphate pyrophosphorylase deficiency which causes an accumulation of ITP in red blood cells. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jun 2012]
ITPA Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 35
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • inosine triphosphatase deficiency
    Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 20-3219057-G-A is Benign according to our data. Variant chr20-3219057-G-A is described in ClinVar as Benign. ClinVar VariationId is 3256808.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.976 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000609835.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ITPA
NM_033453.4
MANE Select
c.411+425G>A
intron
N/ANP_258412.1
ITPA
NM_001424408.1
c.411+425G>A
intron
N/ANP_001411337.1
ITPA
NM_001424409.1
c.537+425G>A
intron
N/ANP_001411338.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ITPA
ENST00000609835.5
TSL:1
n.890G>A
non_coding_transcript_exon
Exon 5 of 5
ITPA
ENST00000380113.8
TSL:1 MANE Select
c.411+425G>A
intron
N/AENSP00000369456.3
ITPA
ENST00000455664.6
TSL:1
c.360+425G>A
intron
N/AENSP00000413282.1

Frequencies

GnomAD3 genomes
AF:
0.894
AC:
135869
AN:
151924
Hom.:
60993
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.961
Gnomad AMI
AF:
0.900
Gnomad AMR
AF:
0.919
Gnomad ASJ
AF:
0.803
Gnomad EAS
AF:
0.998
Gnomad SAS
AF:
0.903
Gnomad FIN
AF:
0.829
Gnomad MID
AF:
0.758
Gnomad NFE
AF:
0.855
Gnomad OTH
AF:
0.893
GnomAD4 exome
AF:
0.868
AC:
49541
AN:
57046
Hom.:
21654
Cov.:
0
AF XY:
0.870
AC XY:
26314
AN XY:
30232
show subpopulations
African (AFR)
AF:
0.956
AC:
799
AN:
836
American (AMR)
AF:
0.927
AC:
3192
AN:
3444
Ashkenazi Jewish (ASJ)
AF:
0.808
AC:
945
AN:
1170
East Asian (EAS)
AF:
1.00
AC:
2706
AN:
2706
South Asian (SAS)
AF:
0.885
AC:
8977
AN:
10144
European-Finnish (FIN)
AF:
0.839
AC:
2418
AN:
2882
Middle Eastern (MID)
AF:
0.853
AC:
133
AN:
156
European-Non Finnish (NFE)
AF:
0.849
AC:
27769
AN:
32692
Other (OTH)
AF:
0.863
AC:
2602
AN:
3016
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
306
611
917
1222
1528
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
222
444
666
888
1110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.894
AC:
135994
AN:
152042
Hom.:
61057
Cov.:
30
AF XY:
0.895
AC XY:
66490
AN XY:
74310
show subpopulations
African (AFR)
AF:
0.961
AC:
39866
AN:
41480
American (AMR)
AF:
0.919
AC:
14037
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.803
AC:
2785
AN:
3470
East Asian (EAS)
AF:
0.998
AC:
5176
AN:
5184
South Asian (SAS)
AF:
0.903
AC:
4362
AN:
4828
European-Finnish (FIN)
AF:
0.829
AC:
8709
AN:
10510
Middle Eastern (MID)
AF:
0.760
AC:
222
AN:
292
European-Non Finnish (NFE)
AF:
0.855
AC:
58131
AN:
67990
Other (OTH)
AF:
0.894
AC:
1885
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
697
1394
2091
2788
3485
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
898
1796
2694
3592
4490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.864
Hom.:
35243
Bravo
AF:
0.902
Asia WGS
AF:
0.954
AC:
3312
AN:
3474

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.78
DANN
Benign
0.39
PhyloP100
-0.82
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2422862; hg19: chr20-3199703; API